This story was originally published on January 21, 2021

New York City has brought a number of new vaccine hubs and facilities online as it ramps up for mass vaccinations after a rocky early rollout of the process. But even robust infrastructure won't help the city if it runs out of doses of the scarce vaccine — which it is expected to as early as the end of the week.

A new 24/7 vaccine site opened last week alongside Brooklyn Army Terminal, a former military supply base that is now used as a commercial hub. One of the first such facilities in the city, it was originally constructed for COVID-19 testing but has been retrofitted to vaccinate up to 2,000 people per day when fully operational. Each borough will have a similar facility with an additional mega-site expected to open at Citi Field in Queens within the week.

Patients receiving their vaccines on the first few days of operations didn't seem to mind the series of steps involved, including a mandatory and somewhat complicated reservation system, a wait in line, and registration.

Jennifer Weyburn, an educator, said her friends and colleagues walked her through the appropriate steps to register.

"I mean it wasn't intuitive, but you figured it out," she said.

Authorities hoped the reservation process would keep lines from forming or crowds from gathering. Still, wait times were hours long at facilities in Staten Island over the weekend, according to SILive. Patients at the Brooklyn site reported quick wait times by comparison.

Rebecca Wexler, a teacher, said the entire process took her about an hour and 15 minutes from start to finish.

"It was flawless for me. I'm surprised and happy to say," she said.

There was also a consistent flow of curious New Yorkers without appointments wandering up to inquire about the shot.

"It's by appointment. And we're trying to reiterate that, but of course, people are used to using our testing sites as walk-in only," said Dr. Jonathan Jimenez, medical director of community testing and vaccination sites with NYC Health + Hospitals.

Once inside, patients are escorted to one of 23 pods, where they will meet with a nurse practitioner to receive their injection. Brooklyn Army Terminal offers the Moderna vaccine, which, according to the CDC, is 94.1 percent effective in preventing COVID-19 illness. After they receive the shot, patients are herded toward a waiting area, where they are observed by medical professionals for any reaction to the drug. The CDC recommends 15 to 30 minutes of observation, depending on medical history.

After receiving her first dose of the Moderna vaccine, Weyburn said she was elated to receive the shot earlier than anticipated. But she wasn't ready to let her guard down yet.

"I guess the big thing is not to get over-elated and to keep on doing social distancing, and wearing masks," she said.

Especially as more New Yorkers become eligible for the coronavirus vaccine, facilities like the one at Brooklyn Army Terminal will play a crucial part in New York City's strategy to ramp up vaccinations. But Mayor Bill de Blasio said shortages of doses could impair those efforts. The city already canceled or rescheduled some 23,000 vaccine appointments due to inadequate supply, exacerbated by a delivery delay of the Moderna vaccine, the Associated Press reported.

New York Governor Andrew Cuomo said he expects doses across the state to run dry within days.

Close to 908,000 people across the state have received their first dose of the vaccine, and 136,500 have received their second dose, according to New York state's COVID-19 tracker. Even so, the pressure is on officials to continue the rollout uninterrupted as hospitalizations creep up to levels not seen since the early days of the pandemic.

This story was photographed and edited by Douglas C. Murray

Share:
More In Politics
Stocks Close Monday at Session Lows
Stocks began the week closing at session lows on a day when bond yields rose and President Biden decided to stick with Jerome Powell as Fed Chair. Bryan Lee, Chief Investment Officer at Blue Zone Wealth Advisors, joins Cheddar News' Closing Bell, where he breaks down the day's activity and discusses what the Fed now needs to do going forward.
Markets, Treasuries Tick Up Amid Jerome Powell's Re-Nomination to Fed Chair Position
President Joe Biden announced Monday he is re-nominating Federal Reserve Chairman Jerome Powell after weeks of speculation that he would choose Democrat and Fed Governor Lael Brainard to fill the role. Biden could be looking for continuity as the U.S. continues to grapple with COVID-19 and high inflation, and investors could be on the same page: markets and treasuries ticked up after the White House made the announcement. MarketWatch Senior Reporter Greg Robb joins Cheddar News' Closing Bell to discuss Powell's re-nomination, what we can expect from the Fed's December meeting, whether it will speed up its taper timeline, and more.
Biden Choice to Keep Jerome Powell at Fed Was 'Path of Least Resistance'
President Joe Biden named Jerome Powell, initially appointed by President Trump, to keep his seat as the chair of the Federal Reserve on Monday amid the ongoing challenges of the pandemic, inflation, and unemployment. David Beckworth, a former international economist for the Treasury Department and a senior fellow with the Mercatus Center, joined Cheddar to discuss what he sees as the practicality of Biden's decision. "What Powell brings to the table is he's built up political capital with Republicans and Democrats," he said. "It's easy for him to get the job done. I think in one way he was the path of least resistance for the president."
Elizabeth Holmes to Resume Theranos Testimony
In a surprise turn of events, Elizabeth Holmes took the stand in her own defense on Friday and is expected to continue her testimony later today. Holmes, who founded a blood testing start-up Theranos back in 2003, faces 11 counts of wire fraud as well as conspiracy to commit wire fraud. Aron Solomon, Chief Legal Analyst, Esquire Digital joined Cheddar's Opening Bell to discuss.
House Passes Build Back Better Plan, Goes to Senate
The House narrowly passed President Biden's $1.7 trillion Build Back Better bill, the largest expansion of the social safety net in decades. The final vote was 220 to 213, with only one Democrat joining all Republicans in opposing the bill. It now heads to the Senate, where it faces an uncertain fate. Jennifer Haberkorn, congressional reporter for the Los Angeles Times, joins Cheddar News' Closing Bell, where she breaks down the current version of the bill, where it goes next, and what it could mean for the country if it eventually reaches the president's desk.
Load More